Genmab A GMAB
NASDAQ GMAB
$39.83 +0.26 (+0.66%)
As of: Oct 22, 2026 · 10:10 AM EDT

Genmab A (GMAB) Non Operating Income (2023 - 2026)

Updated

Analysis

Genmab A (GMAB) Non Operating Income (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn -
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn -
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn -
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn -
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn -
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn 387.00 Mn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn -
10 Genmab A 2.58 Bn -2.80 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -106.00 Mn
Sep 30, 2025 23.00 Mn
Mar 31, 2025 56.00 Mn
Sep 30, 2024 -57.00 Mn
Mar 31, 2024 -915.00 Mn
Sep 30, 2023 985.00 Mn
Mar 31, 2023 151.00 Mn
API Access

Genmab A Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=GMAB&period=max&api_key=YOUR_API_KEY